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Pate, Predictors, and Consequences of
emodynamic Depression After Carotid Artery Stenting
ishi Gupta, MD,*‡ Alex Abou-Chebl, MD,* Christopher T. Bajzer, MD,†
. Christian Schumacher, MD,§ Jay S. Yadav, MD*†
leveland, Ohio; Pittsburgh, Pennsylvania; and New York, New York
OBJECTIVES We sought to determine the frequency, predictors, and consequences of hemodynamic
depression (HD) after carotid artery stenting (CAS).
BACKGROUND Hemodynamic depression has been reported after carotid artery stenting CAS and carotid
endarterectomy (CEA).
METHODS We retrospectively analyzed data on 500 consecutive CAS procedures performed over a
5-year period. Hemodynamic depression was defined as periprocedural hypotension (systolic
blood pressure 90 mm Hg) or bradycardia (heart rate 60 beats/s). Univariate and
multivariate binary logistic regression models were used to determine the predictors and
consequences of HD and persistent HD.
RESULTS The mean age of the patients was 70.5  10 years, and 69% were men. Hemodynamic
depression occurred during 210 procedures (42%), whereas persistent HD developed in 84
procedures (17%). Features that independently predicted HD included lesions involving the
carotid bulb (odds ratio [OR] 2.18 [range 1.46 to 3.26], p  0.0001) or the presence of a
calcified plaque (OR 1.89 [range 1.25 to 2.84], p  0.002). Prior ipsilateral CEA was
associated with reduced risk of HD (OR 0.35 [range 0.20 to 0.60], p 0.0001). Patients who
developed persistent HD were at a significantly increased risk of a periprocedural major
adverse clinical event (OR 3.05 [range 1.35 to 5.23], p  0.02) or stroke (OR 3.34 [range
1.13 to 9.90], p  0.03).
CONCLUSIONS Hemodynamic depression is common after CAS, particularly in patients with a calcified
plaque in the carotid bulb, but is easily treated with conventional methods. Patients who
develop persistent HD are at an increased risk of periprocedural major adverse clinical events
and stroke. (J Am Coll Cardiol 2006;47:1538–43) © 2006 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.08.079Cardiology Foundation
w
d
r
l
n
f
r
c
C
v
p
r
t
b
o
p
w
e
d
d
r
c
c
s
harotid artery stenting (CAS) is being used more frequently
s an alternative to carotid endarterectomy (CEA) in high-
urgical-risk patients. Hemodynamic depression (HD) has
een described after CEA owing to the manipulation of the
arotid sinus (1), and there have been reports regarding the
requency and predictors of HD after CAS (2–4) and its
ossible association with adverse clinical outcomes (4,5).
hese studies involved small numbers of patients, but all
oncluded that HD is common with CAS. Disagreement
xists as to the clinical relevance of HD and which clinical
nd angiographic factors may predict it. We performed this
tudy on a large, consecutive group of patients and report
he frequency, predictors, and consequences of HD in our
ohort of patients.
UBJECTS AND METHODS
his retrospective study includes 461 consecutive patients
ho underwent 500 carotid stent procedures for atheroscle-
otic stenoses between February 1998 and July 2003 and
From *Interventional Neurology, Section of Stroke and Neurological Critical Care,
nd †Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleve-
and, Ohio; ‡Department of Neurology, University of Pittsburgh Medical Center,
troke Institute, Pittsburgh, Pennsylvania; and §Department of Neurology, Columbia
niversity College of Physicians and Surgeons, New York, New York. Dr. Yadav is
he inventor of the Angioguard embolic protection device that was used in some of the
arotid stent procedures.p
Manuscript received April 20, 2005; revised manuscript received August 15, 2005,
ccepted August 22, 2005.ho were prospectively entered into our interventional
atabase. All patients were considered to be at high surgical
isk on the basis of age 80 years, prior injury to the
aryngeal nerve, the presence of clinically significant coro-
ary artery disease (abnormal stress test, congestive heart
ailure, more than two major arteries diseased 70% or
equiring open-heart surgery), severe pulmonary disease,
ontralateral carotid occlusion, a history of prior ipsilateral
EA, neck exploration, or radiation therapy. Three inter-
entionalists performed all of the CAS procedures. Ap-
roval for this study was obtained from the institutional
eview board of our hospital.
We defined HD as symptomatic or asymptomatic hypo-
ension (systolic blood pressure [SBP] 90 mm Hg) or
radycardia (heart rate [HR]60 beats/min), regardless
f the need for vasopressor support, atropine, or a
acemaker. Vasopressor agents were given to patients in
hom fluid boluses or a dose of 60 mg of oral pseudo-
phedrine failed. Atropine was given for patients who
eveloped a 20 beats/min drop in their heart rate
uring predilation or transient asystole that did not
espond to the patient coughing. Patients who required
ontinuous vasopressor infusion after the procedure were
onsidered to have persistent HD. This definition was
elected arbitrarily to represent the population felt to
ave a more profound hemodynamic change in the
eriprocedural period.
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April 18, 2006:1538–43 Hemodynamic Depression After Carotid Stentingata collection. The prospectively maintained database of
ll carotid procedures performed in our laboratory was
etrospectively queried for the following information: pa-
ient demographics (age, gender, risk factor profile, use of
eta-blockers), history of contralateral carotid occlusion,
istory of irradiation to the neck, history of stroke or
ransient ischemic attack (TIA), stent diameter, diameter of
alloon used before and after dilation, arterial lumen diam-
ter, percent stenosis of lesion, lesion location (common
arotid, bulb, internal distal to bulb, and so on), presence of
alcification and ulceration within the lesion, blood pressure
eading recorded every 5 min via the arterial sheath, heart
ate recorded every 5 min on a rhythm strip, hypotension,
asopressor support and atropine use, date and time of the
rocedure, and date and time of discharge. In addition,
atients who developed major adverse clinical events
MACE), defined as myocardial infarction (MI), stroke, or
eath, were recorded within the periprocedural period.
atients with TIA, defined as resolution of a focal neuro-
ogic deficit within 24 h, were also recorded but not
ncluded as a MACE. To ensure that all periprocedural
vents were captured and to corroborate the data from the
atabase, the charts and the angiograms of all the patients
ere also reviewed and analyzed for the same data.
The length of stay of patients was calculated from the
ime of the procedure to the time of hospital discharge.
ixteen patients had preplanned medical or surgical inter-
entions to be performed following CAS and were not
ncluded in the length-of-stay analysis.
AS procedure. The technique of CAS has been pub-
ished elsewhere (6). Various embolic protection devices
ere utilized during CAS procedures, including EpiFilter
ire (Boston-Scientific, Fremont, California), Accunet
Guidant Corp., Indianapolis, Indiana), Angioguard (Cor-
is Corp., Miami Lakes, Florida), and Percusruge (Medtronic
nc., Minneapolis, Minnesota). In addition, all patients had
reatine phosphokinase, creatine phosphokinase-MB fraction,
nd troponin levels drawn before and after the procedure. All
AS procedures were performed without general anesthesia
nd with continuous arterial pressure and electrocardio-
raphic monitoring. Intravenous anxiolytics and analgesics
Abbreviations and Acronyms
CAS  carotid artery stenting
CEA  carotid endarterectomy
DM  diabetes mellitus
HD  hemodynamic depression
HR  heart rate
MACE  major adverse clinical events
MI  myocardial infarction
NS  normal saline
OR  odds ratio
SBP  systolic blood pressure
TIA  transient ischemic attackere used rarely in very anxious patients; all other patients peceived local access site anesthesia only. All patients were
nstructed to take their usual oral antihypertensive agents
he morning of the procedure. Blood pressure was moni-
ored continuously through the arterial sheath while heart
ate was continuously monitored via a rhythm strip. All
atients had a SBP 100 mm Hg at the time of insertion
f the arterial sheath. Two large-bore peripheral intravenous
atheters were placed in every patient, through which
ormal saline (NS) was infused from the beginning of the
rocedure; the rate of infusion was adjusted based on a
atient’s known left ventricular ejection fraction and fluid
tatus. Atropine and other anti-cholinergic agents were not
iven prophylactically to any patient nor did patients receive
entral venous lines or pacemakers prophylactically. Patients
ere instructed before the procedure to cough hard when
sked to, which they practiced before the start of the
rocedure. If bradycardia or a 20 beats/min decrease in
aseline HR occurred with lesion pre-dilation, patients were
reated with 0.5 mg of atropine before stent deployment and
ost-dilation. If hypotension occurred, patients received a
50 to 500 cc bolus of NS. If the hypotension or bradycardia
as persistent, patients were treated with additional fluids,
tropine, or 2 to 6 g/kg boluses of norepinephrine. If
systole occurred, patients were asked to cough several
imes, and the angioplasty balloon was rapidly deflated.
Continuous NS infusions were continued in all patients
nd were adjusted to maintain normotension. Patients with
symptomatic, persistent hypotension received oral pseudo-
phedrine 30 to 60 mg two to three times daily. Those with
ontinued hypotension despite fluids and pseudoephedrine
enerally received vasopressor support with dopamine. In all
ases, oral antihypertensive agents were not resumed except
n those patients who had significant hypertension or those
ho were at risk for hyperperfusion syndrome and intrace-
ebral hemorrhage. Strict bed rest was maintained in all
atients until the following morning, when orthostatic vital
igns were obtained; only those patients without orthostatic
ypotension and who were otherwise doing well were
ischarged. Patients with orthostatic hypotension were ob-
erved for another 24 h or until the orthostasis resolved.
tatistics. Baseline characteristics were compared among
he HD, persistent HD, and non-HD groups using the
isher exact test for categorical variables and the Student t
est for continuous variables. A p value of 0.05 was
onsidered significant. A multivariate binary logistic regres-
ion analysis was performed to determine which clinical and
ngiographic variables would independently predict the
evelopment of HD and persistent HD during CAS. In
ddition, a binary logistic regression model was constructed
o determine the variables that independently predicted
atients developing a MACE, stroke, MI, death, or TIA.
ariables with a p value0.10 were entered into the logistic
egression model, but only variables with a p value 0.05
ere considered statistically significant as independent
redictors.
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Hemodynamic Depression After Carotid Stenting April 18, 2006:1538–43ESULTS
total of 500 CAS procedures were performed on separate
ccasions in 461 patients. The baseline characteristics of the
ohort are shown in Table 1. The overall technical success
ate was 99.6%, with two failed procedures due to inability
o cross the lesion. Only one patient (0.2%) required a
acemaker after the procedure for third-degree atrioventric-
lar block. Periprocedural HD was noted in 210 procedures
42%). Bradycardia developed during 136 procedures (27%),
ith 116 (85% of patients with bradycardia) of these
ccurring during the procedure and 20 (15% of patients
ith bradycardia) after the procedure. Isolated bradycardia
ithout hypotension occurred in 67 procedures (13%).
ypotension occurred in 134 procedures (27%); 79 (59% of
ll hypotension patients) developed during the procedure
nd 55 (41% of all hypotension patients) after the procedure.
asopressor treatment (one-time bolus or continuous infusion)
as required in 89 procedures (18%), whereas atropine was
iven in 89 procedures (18%). The combination of atropine
nd vasopressor support was required in 32 procedures (7%).
Persistent HD developed in 84 cases (17% of all inter-
entions but 40% of all HD patients). Patients who devel-
ped persistent HD were more likely to have had intrapro-
edural HD (odds ratio [OR] 1.9 [range 1.6 to 2.1], p 
able 1. Association of Periprocedural Hemodynamic Depression
Yes
(n  210)
linical characteristics
Age (yrs, mean  SD) 71  10
Women, n (%) 67 (32)
Symptomatic carotid stenosis, n (%) 53 (25)
Prior stroke, n (%) 50 (24)
Diabetes mellitus, n (%) 88 (42)
Coronary artery disease, n (%) 169 (80)
Permanent pacemaker, n (%) 11 (5)
Hypertension, n (%) 173 (82)
Hyperlipidemia, n (%) 160 (76)
Smoking, n (%) 136 (65)
Beta-blocker use, n (%) 71 (34)
Prior ipsilateral CEA, n (%) 21 (10)
History of neck irradiation, n (%) 12 (6)
SBP before procedure (mm Hg, mean  SD) 151  26
HR before procedure (beats/min, mean  SD) 70  12
ngiographic features of carotid stenosis
Carotid stenosis (%, mean  SD) 85  10
Before dilation balloon diameter (mm, mean  SD) 3.9  1.0
After dilation balloon diameter (mm, mean  SD) 6.7  1.4
Balloon-to-artery ratio (mean  SD) 0.94  0.12
Stent diameter (mm, mean  SD) 7.7  1.4
Lesion length (mm, mean  SD) 18  9
Eccentric plaque, n (%) 130 (62)
Ulcerated plaque, n (%) 80 (38)
Calcified plaque, n (%) 68 (32)
Lesion involves carotid bulb, n (%) 142 (68)
Contralateral carotid occlusion, n (%) 34 (16)
ignificant p values are in bold. *Chi-square test. †Student t test for continuous var
CEA  carotid endarterectomy; HD  hemodynamic depression; HR  heart r.0001). Bradycardia was evident in 41 patients with per- pistent HD (49%). Patients received intravenous vasopres-
ors for a mean time of 15.9  16.4 h (median  12 h,
ange 1 to 96 h).
Hemodynamic depression occurred significantly less of-
en in smokers and in patients with a previous CEA
ompared with nonsmokers or patients with de novo le-
ions, respectively (Table 1). A history of diabetes mellitus
DM) and use of beta-blockers were additional variables
ound to reduce the risk of developing persistent HD. None
f the remaining clinical baseline characteristics was associ-
ted with HD or persistent HD. Atherosclerotic plaques
ocated at the carotid bulb and plaques showing calcification
r ulceration on angiography were significantly associated
ith HD and persistent HD, whereas stenosis grade, lesion
ength, eccentric plaque location, balloon/artery ratio, and
tent diameter were not (Table 1). Our results were used to
onstruct a model to predict the occurrence of HD. Multi-
ariate binary logistic regression analysis revealed that de
ovo lesions, plaque location at the carotid bulb, and plaque
alcification were independent variables associated with HD
Table 2). In patients who developed persistent HD, plaque
lceration was additionally associated, whereas DM was
ound to independently reduce the risk.
In a binary logistic regression model, patients with
h Baseline Clinical and Angiographic Characteristics
HD Persistent HD
No
n  290) p Value
Yes
(n  84)
No
(n  416) p Value
70  10 0.58† 71  9 70  10 0.65†
88 (30) 0.71* 30 (36) 125 (30) 0.30*
63 (22) 0.36* 18 (21) 98 (24) 0.67*
67 (23) 0.49* 20 (24) 97 (23) 0.08*
105 (36) 0.20* 24 (29) 169 (41) 0.04*
215 (74) 0.10* 68 (81) 316 (76) 0.32*
22 (8) 0.27* 6 (7) 27 (6) 0.85*
246 (85) 0.46* 65 (77) 354 (85) 0.08*
211 (73) 0.39* 68 (81) 303 (73) 0.12*
215 (74) 0.02* 51 (61) 300 (72) 0.04*
116 (40) 0.16* 23 (27) 164 (39) 0.04*
85 (29) 0.001* 5 (6) 101 (24) 0.0001*
15 (5) 0.62* 5 (6) 22 (5) 0.95*
54  26 0.15† 150  26 153  26 0.28†
71  11 0.62† 69  11 71  12 0.34†
86  10 0.79† 86  8 85  10 0.63†
3.7  1.2 0.10† 4.0  0.9 3.7  1.2 0.06†
6.6  1.4 0.53† 6.8  1.4 6.5  1.4 0.11†
.88  0.11 0.25† 0.95  0.10 0.89  0.13 0.16†
7.6  1.4 0.29† 7.9  1.3 7.5  1.4 0.06†
17  8 0.67† 18  9 17  8 0.66†
168 (58) 0.37* 55 (65) 243 (58) 0.23*
84 (29) 0.004* 41 (49) 123 (30) 0.001*
92 (18) 0.0001* 42 (50) 118 (28) 0.0001*
151 (52) 0.0001* 66 (79) 227 (55) 0.0001*
35 (12) 0.20* 15 (18) 54 (13) 0.25*
BP  systolic blood pressure.Wit
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April 18, 2006:1538–43 Hemodynamic Depression After Carotid Stentingping a MACE (OR 3.05 [range 1.35 to 5.23], p  0.02)
r stroke (OR 3.34 [range 1.13 to 9.90], p  0.03). No
linical or angiographic variable was predictive of MI or
eath. In a multivariate analysis, patients with ulcerated
esions were at a significantly higher risk of developing a
IA (OR 8.7 [range 1.67 to 15.5], p  0.01). Patients who
eveloped HD had significantly longer hospitalizations
ompared with patients without HD (3.4  6.5 days vs.
.8  1.9 days, p  0.0001).
ISCUSSION
he carotid bulb baroreceptors mediate changes in blood
ressure and heart rate via the medullary vasomotor nuclei
n order to maintain a hemodynamic steady state and
dequate cerebral perfusion. Distension of the carotid bulb
eads to stimulation of the baroreceptors, which in turn
auses reflex inhibition of adrenergic output to the periph-
ral vasculature and increased cardiac parasympathetic stim-
lation; hypotension and bradycardia are the consequences
7). Early experiences with CEA showed that transient
aroreceptor dysfunction was common (8), and more recent
xperience has shown that postoperative hypertension, and
ot hypotension, may be associated with higher rates of
troke or death (9). With CAS, angioplasty and distension
f the carotid bulb causes baroreceptor stimulation and HD.
his has been reported to occur in 19% to 68% of patients,
ith unclear clinical consequences (4,10). Because not all
atients have HD with CAS, studies inquiring into possible
redisposing factors have suggested that older age (11),
istory of coronary artery disease (10), larger balloon diam-
ters (4), lesion location (3), contralateral carotid stenosis
60% (3), or elevated SBP 180 mm Hg before the
rocedure (5) may predispose patients to HD. Each of these
tudies reported predictors based on a small number of
atients relative to the number of variables considered in the
nalysis. Our analysis shows that patients who have lesions
able 2. Binary Logistic Regression Model to Predict
emodynamic Depression
Variable Odds ratio 95% CI p Value
D
Smoking history 0.74 0.49–1.11 0.14
Calcified plaque 1.89 1.25–2.84 0.002
Ulcerated plaque 1.49 0.99–2.23 0.052
Lesion involves bulb 2.18 1.46–3.26 0.0001
Prior ipsilateral CEA 0.35 0.20–0.60 0.0001
ersistent HD
Diabetes mellitus 0.44 0.25–0.78 0.003
Smoking history 0.63 0.37–1.07 0.08
Beta-blocker use 0.62 0.35–1.08 0.09
Calcified plaque 2.00 1.20–3.32 0.008
Ulcerated plaque 1.86 1.10–3.13 0.02
Lesion involves bulb 2.57 1.42–4.68 0.002
Prior ipsilateral CEA 0.25 0.10–0.67 0.005
ignificant p values are in bold.
CEA  carotid endarterectomy; CI  confidence interval; HD  hemodynamic
epression.nvolving the carotid bulb or heavy calcification are at a eigher risk of developing HD and persistent HD. Other
tudies have confirmed that lesions involving the carotid
ifurcation would predict the presence of HD after CAS
3,12). This is likely to be due to the higher concentration
f baroreceptors at this location (12).
Patients who had a restenosis after a prior ipsilateral CEA
ere less likely to develop HD in our cohort, a finding
bserved by others (2,13). This is likely from the reduced
umber of baroreceptors in the carotid bulb after CEA. In
ddition, scar formation after endarterectomy causes a
eduction in arterial compliance and may require more
istension for the baroreceptors to be stimulated (14).
atients with a history of smoking were also at a reduced
isk from developing HD and persistent HD in our univar-
ate analysis, but this was not found to be an independent
isk factor in our logistic regression model. It is plausible for
mokers to be protected from HD during CAS, as smoking
s known to increase sympathetic tone through the release of
pinephrine and norepinephrine, thereby raising blood pres-
ure and heart rate (15). Habitual smoking may impair the
aroreceptors through the reduction of arterial compliance
f the entire vasculature, which would reduce baroreceptor
timulation (16). Diabetes mellitus was found to be an
ndependent variable that reduced the risk of patients
eveloping persistent HD. It is well known that DM affects
ardiovascular autonomic nerves (17). Early observations
evealed that patients with DM had an attenuated parasym-
athetic response with elevations in arterial pressure (18).
ince then, studies have shown that the cardiovagal limb of
he baroreflex is impaired in patients with DM, whereas
ympathetic output may be normal to slightly attenuated
19). This observation is consistent with what we have
ound, as patients with DM were protected from persistent
D, likely because of an impaired ability to develop reflex
radycardia during balloon inflation and stent deployment.
Another unique finding with our analysis was the obser-
ation that patients with a calcified plaque were at a
ignificant risk of developing HD, which predisposed them
o adverse cerebrovascular events. The presence of an
lcerated plaque, on the other hand, did not independently
redict HD but did predict persistent HD, which in turn
as associated with a significant risk of a MACE. This is
onsistent with the risks associated with plaque excision by
ndarterectomy. Histopathologic studies after CEA have
hown that calcified plaques are more likely to be “stable,”
ith a low risk of thromboembolism or plaque rupture in
he carotid artery (20). In contrast, ulcerated plaques, which
ay be more friable, have a higher rate of rupture and thus
higher incidence of embolism and strokes in the periop-
rative period (21). This is the likely explanation for
lcerated lesions being an independent predictor of patients
eveloping TIAs perioperatively. Plaque morphology has
ot been rigorously studied after CAS because of the lack of
fter-surgical specimens. The dichotomy between CAS and
EA in MACE risk based on plaque calcification may bexplained by the fact that calcified plaques may require
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Hemodynamic Depression After Carotid Stenting April 18, 2006:1538–43igher angioplasty balloon pressures for lesion dilation. In
ddition, thick calcified plaques may transmit the balloon
ressure more efficiently to the baroreceptors, increasing the
tretching of the baroreceptors (22). These two factors may
esult in more profound HD, which we have found to be
ssociated with adverse events.
There has been considerable debate in the literature with
egard to HD as a predictor of adverse outcomes peripro-
edurally. One group reported that patients with large
uctuations (107 mm Hg change) in SBP after CAS were
t a significantly higher risk of stroke, whereas patients with
maller fluctuations (50 mm Hg) did not experience an
dverse neurologic event (5). Another group found that
atients with hypotension were at increased risk of in-
ospital minor strokes and death at six months when
ompared with patients who did not have hypotension (4).
ur experience with a large cohort reveals that persistent
D, and not HD itself, is a risk factor for the development
f adverse cerebrovascular events. Embolization occurs in all
arotid stenting procedures, and embolic protection devices
arkedly reduce the number of particles that reach the brain
23). Not all emboli are eliminated, however, and hypoten-
ion may impair the washout of emboli in the distal
ntracranial circulation and increase the risk of clinically
vident cerebral ischemia (24).
Consideration has been given by some authors to aggres-
ively treating or pre-treating hypotension or bradycardia
eriprocedurally. Leisch et al. (3) showed that pre-treatment
f patients who developed asystole after the first balloon
nflation with atropine prevented a second episode of
radycardia or asystole in 37 of 39 patients (95%). No
atient in their cohort required transvenous pacing. Another
roup (25) utilized transvenous pacing prophylactically in
3 patients in order to prevent bradycardia and hypotension.
nterestingly, 23 of the patients (62%) had an activation of
he transvenous pacemaker, confirming how common HD
s with CAS. Of 500 consecutive patients treated at our
enter, only one patient required a pacemaker; all others
ere managed medically. Because profound vasodilation is a
ajor component of the carotid bulb reflex, volume expan-
ion may prevent or attenuate the hypotensive response. We
re-treated, with volume expansion, all of our patients
xcept those with known severely impaired left ventricular
unction. None of our patients failed to respond to this
reatment, alone or in combination with vasopressors and
tropine. On the basis of our experience, we feel that the use
f prophylactic transvenous pacing is not warranted and may
ncrease complications such as ventricular arrhythmias or
erforation (26). Pharmacologic pre-treatment is also not
enign. The routine use of atropine, especially in an elderly
opulation with coronary artery disease, may lead to poten-
ial complications, including confusion, urinary retention
27), and arrhythmias (28). To date, no study has been
erformed to determine whether aggressively treating pa-
ients who develop “mild” HD may prevent persistent HD
nd thus reduce potential adverse vascular events.There are some weaknesses in our study. The first is that
e are unable to analyze the effect of patients taking their
lood pressure medications the day of the procedure. This
ay have contributed to the presence or duration of HD in
ome patients, although an analysis of patients taking
eta-blockers did not have an effect on the multivariate
nalysis. Second, there were some patients who had a
aseline HR near the threshold set for inclusion as HD in
ur study. In studying the persistent HD group, we ex-
luded any patient with isolated bradycardia and focused on
atients requiring continuous vasopressor therapy. Third,
ome patients with hematomas required transfusions and
ay have had drops in their blood pressure as a result of
lood loss. The majority of these patients became hypoten-
ive during the procedure, and thus we included all of these
atients in the HD and persistent HD analysis. Last, we did
ot record the balloon inflation pressures in the database.
e do present the maximum balloon diameters used before
nd after dilation, however. It is possible that some lesions
ere not fully dilated to the maximum balloon diameter.
espite these shortcomings, we feel this analysis can aid
linicians performing these procedures in predicting pa-
ients at risk of HD or persistent HD.
onclusions. The development of HD with CAS is com-
on. These hemodynamic changes are more likely to occur
n patients with calcified and ulcerated de novo lesions
ocated at the carotid bulb, whereas patients with a prior
psilateral CEA are less likely to develop HD. Hemody-
amic depression and persistent HD can be easily managed
ith conventional pharmacologic agents and volume expan-
ion. Persistent HD is associated with adverse clinical events
n high-surgical-risk patients. Further studies are required
o determine whether pre-treating high-risk patients with
uids, vasopressors, or anti-cholinergics may prevent per-
istent HD and subsequently reduce the risk of adverse
ascular events.
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